SABA Trademark

Trademark Overview

On Monday, June 6, 2022, a trademark application was filed for SABA with the United States Patent and Trademark Office. The USPTO has given the SABA trademark a serial number of 79346701. The federal status of this trademark filing is REGISTERED as of Tuesday, July 9, 2024. This trademark is owned by SABA ILAÇ SANAYI VE TICARET ANONIM SIRKETI. The SABA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in treating by inhibiting the growth of tumors, and for treatment of the nervous systems, orthopedic and musculoskeletal disease, respiratory disease, genital and urologic disease, cardiovascular disease, dermatological disease, metabolic disease, gastrointestinal disease, ophthalmological disease including artificial tears and lubricant eyedrops, cancer and diseases of the blood, and for use in treating immune function, and antiinfectives for systemic use
saba

General Information

Serial Number79346701
Word MarkSABA
Filing DateMonday, June 6, 2022
Status700 - REGISTERED
Status DateTuesday, July 9, 2024
Registration Number7435201
Registration DateTuesday, July 9, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Description of MarkThe mark consists of a vertical rectangle in blue with a white curved line down the middle and a white horizontal rectangle at the bottom with the term "SABA" in blue inside.
Goods and ServicesPharmaceutical preparations for use in treating by inhibiting the growth of tumors, and for treatment of the nervous systems, orthopedic and musculoskeletal disease, respiratory disease, genital and urologic disease, cardiovascular disease, dermatological disease, metabolic disease, gastrointestinal disease, ophthalmological disease including artificial tears and lubricant eyedrops, cancer and diseases of the blood, and for use in treating immune function, and antiinfectives for systemic use
Indication of Colors claimedThe color(s) blue and white is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSABA ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTR
Party NameSABA ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTR
Party NameSABA ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTR

Trademark Events

Event DateEvent Description
Thursday, August 4, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 9, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, March 21, 2023ASSIGNED TO EXAMINER
Wednesday, March 29, 2023NON-FINAL ACTION WRITTEN
Thursday, March 30, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, May 21, 2023REFUSAL PROCESSED BY MPU
Sunday, May 21, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 12, 2023REFUSAL PROCESSED BY IB
Monday, October 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 13, 2023FINAL REFUSAL WRITTEN
Monday, November 13, 2023FINAL REFUSAL E-MAILED
Monday, November 13, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, January 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, January 11, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 30, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, February 12, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, February 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 29, 2024NOTIFICATION PROCESSED BY IB
Tuesday, July 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, December 18, 2024GENERIC MADRID TRANSACTION CREATED
Wednesday, December 18, 2024GENERIC MADRID TRANSACTION SENT TO IB
Saturday, February 8, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, October 18, 2025NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

saba disease treating tears lubricant artificial including gastrointestinal ophthalmological eyedrops cancer